Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH – Proteomic and lipidomic insight

Article

Abstract: Background & aims: Currently there is no FDA-approved therapy for nonalcoholic steatohepatitis (NASH

Palabras claves:

Endoplasmic reticulum stress, Lipidomic, mitochondrial dysfunction, NASH, Omega-3 PUFA, Proteomic

Autores:

Alves V.A.F., Carrilho F.J., Fernanda Bertuccez Cordeiro, Nogueira M.A., Okada L.S.d.R.R., Oliveira C.P., Puri P., Silva I.D.C.G.d., Stefano J.T., Torrinhas R.S., Waitzberg D.L.

Fuentes:

scopus